Key result
New 2024 ESC chronic coronary syndrome guidelines advocate personalized antianginal therapy via the Diamond Approach.
Why the study?
Following the release of the 2024 European Society of Cardiology guidelines on chronic coronary syndromes, experts sought to critically appraise and comment on the document.
This expert appraisal highlights key shifts in the 2024 ESC CCS guidelines, particularly the focus on ANOCA/INOCA, individualizing treatment via the Diamond Approach, and cautious use of revascularization.
Background: During the 2024 annual meeting in London, The European Society of Cardiology released new guidelines (GLs) on chronic coronary syndromes (CCSs) and simultaneously published them in the European Heart Journal. Method: A few experts on the topic from Europe, South America, India, and Asia, who attended the presentation and the Question and Answer sections, met virtually to comment on the GLs after carefully reading the 123-page document. Result: There is a consensus that the presented GLs are a comprehensive, up-to-date, clear document of the available data on how to diagnose and treat CCSs and a definite step forward compared to all previous GLs. Of particular value are (a) the efforts to link both diagnosis and treatment to the underlying pathophysiology with the recognition that not all the ischaemic episodes are the same; (b) the decision to adopt the graphic of the so-called “Diamond Approach”, although its spirit that no antianginal drug is superior to another is not fully adopted; and (c) the innovative way it condenses and expresses the relevant messages with eye-catching illustrations. Conclusions: The present article summarises and comments on the 123-page GLs, highlighting strengths and weaknesses according to the thoughts of the authors.
No takes yet. Share an insight, caveat, or question.
Ferrari et al. (2025) conducted a review in Chronic Coronary Syndromes. 2024 ESC Guidelines on Chronic Coronary Syndromes was evaluated. The 2024 ESC Guidelines on Chronic Coronary Syndromes emphasize individualizing antianginal therapy through the Diamond Approach and linking diagnosis to underlying pathophysiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: